This post was originally published on this site
“We’re talking to a couple more countries because I would really like on every continent to have MRNA capacity,” he said on a panel at the World Economic Forum annual meeting in Davos.
The company is building or planning to build factories in Canada, Australia, Britain and Kenya, he said.
Its COVID-19 vaccines are made in the United States and Switzerland.
